| P50 | author | Antonino Tuttolomondo | Q41452432 |
| | Antonio Pinto | Q48357572 |
| P2093 | author name string | Clara Camaschella | |
| | Giuseppe Licata | |
| | Domenico Di Raimondo | |
| | Paola Fernandez | |
| P2860 | cites work | Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. | Q50335648 |
| | Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. | Q50335649 |
| | Hereditary ceruloplasmin deficiency with hemosiderosis | Q50335650 |
| | Fine structure of the human ceruloplasmin gene | Q72124159 |
| | Aceruloplasminemia: molecular characterization of this disorder of iron metabolism | Q24564471 |
| | Complete cDNA sequence of human preceruloplasmin | Q24628397 |
| | Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter | Q28145559 |
| | The World Health Organization (WHO) classification of the myeloid neoplasms | Q28202501 |
| | Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain | Q28575311 |
| | A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma | Q30583066 |
| | Human genes encoding prothrombin and ceruloplasmin map to 11p11-q12 and 3q21-24, respectively | Q34180221 |
| | Human ceruloplasmin. Tissue-specific expression of transcripts produced by alternative splicing. | Q34336612 |
| | Use of desferrioxamine in the treatment of aceruloplasminemia | Q34419336 |
| | Molecular and pathological basis of aceruloplasminemia | Q34566666 |
| | Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration | Q34690797 |
| | A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. | Q35466639 |
| | Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation. | Q35596505 |
| | Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux | Q35632453 |
| | Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis | Q35754529 |
| | Mechanisms of copper incorporation into human ceruloplasmin | Q40701100 |
| | Hepatic iron overload in aceruloplasminaemia | Q41774921 |
| | Aceruloplasminemia, an iron metabolic disorder | Q42455448 |
| | Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family | Q42485956 |
| | Increased oxysterols associated with iron accumulation in the brains and visceral organs of acaeruloplasminaemia patients | Q43700332 |
| | Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights | Q44014364 |
| | Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. | Q44117658 |
| | Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate | Q48269852 |
| | CSF abnormalities in patients with aceruloplasminemia | Q48370631 |
| | A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis | Q48484051 |
| | Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture | Q48558289 |
| | Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia | Q48591283 |
| | MR imaging of cerebral cortical involvement in aceruloplasminemia. | Q48972880 |
| P433 | issue | 4 | |
| P921 | main subject | aceruloplasminemia | Q337604 |
| P304 | page(s) | 395-399 | |
| P577 | publication date | 2008-04-12 | |
| P1433 | published in | Internal and emergency medicine | Q26842320 |
| P1476 | title | Aceruloplasminemia: a case report | |
| P478 | volume | 3 | |